• 1
    Kimmel DB 1996 Animal models for in vivo experimentation in osteoporosis research. In: MarcusR, KelseyJ (eds.) Osteoporosis. Academic Press, San Diego, CA, USA, pp. 671690.
  • 2
    Parfitt AM 1990 Bone-forming cells in clinical conditions. In: HallBK (ed.) Bone: The Osteoblast and Osteocyte, vol. 1. Telford Press and CRC Press, Boca Raton, FL, USA, pp. 351429.
  • 3
    Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305311.
  • 4
    Seeman E 1994 Reduced bone density in women with fractures: Contribution of low peak bone density and rapid bone loss. Osteoporos Int 1:1525.
  • 5
    Melton LJ III 1997 The prevalence of osteoporosis. J Bone Miner Res 12:17691771.
  • 6
    Cosman F, Lindsay R 1998 Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 62:475480.
  • 7
    Lane JM, Russell L, Khan SN 2000 Osteoporosis. Clin Orthop 372:139150.
  • 8
    Greenspan SL, Harris ST, Bone H, Miller PD, Orwoll ES, Watts NB, Rosen CJ 2000 Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis. Am Fam Physician 61:27312736.
  • 9
    Seeman E 1993 Osteoporosis in men: Epidemiology, pathophysiology, and treatment possibilities. Am J Med 95:22S28S.
  • 10
    Hesp R, Hulme P, Williams D, Reeve J 1981 The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1-34). Metab Bone Dis Rel 2:331334.
  • 11
    Hodsman AB, Steer BM, Fraher LJ, Drost DJ 1991 Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients. Bone Miner 14:6783.
  • 12
    Slovik DM, Neer RM, Potts JT Jr 1981 Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:12611271.
  • 13
    Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:16181623.
  • 14
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D 1997 A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 82:620628.
  • 15
    Jerome CP, Johnson CS, Vafai HT, Kaplan KC, Bailey J, Capwell B, Fraser F, Hansen L, Ramsay H, Shadoan M, Lees CJ, Thomsen JS, Mosekilde L 1999 Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 25:301309.
  • 16
    Food and Drug Administration 1994 Guidelines for preclinical and clinical evaluation of agents used in the prevention of postmenopausal osteoporosis, FDA Division of Metabolism and Endocrine Drug Projects, Washington D.C.
  • 17
    Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690709.
  • 18
    Tam CS, Heersche JN, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506512.
  • 19
    Beamer WG, Donahue LR, Rosen CJ, Baylink DJ 1996 Genetic variability in adult bone density among inbred strains of mice. Bone 18:397403.
  • 20
    Turner CH, Hsieh YF, Muller R, Bouxsein ML, Baylink DJ, Rosen CJ, Grynpas MD, Donahue LR, Beamer WG 2000 Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res 15:11261131.
  • 21
    Bain SD, Bailey MC, Celino DL, Lantry MM, Edwards MW 1993 High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J Bone Miner Res 8:435442.
  • 22
    Cenci S, Weitzmann MN, Gentile MA, Aisa MC, Pacifici R 2000 M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. J Clin Invest 105:12791287.
  • 23
    Ruegsegger P, Koller B, Muller R 1996 A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58:2429.
  • 24
    Muller R, Ruegsegger P 1997 Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud Health Technol Inform 40:6179.
  • 25
    Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P 1999 Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:11671174.
  • 26
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595610.
  • 27
    Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink DJ 1997 Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21:217223.
  • 28
    Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES 1998 Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res 13:16481656.
  • 29
    Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, Rosen CJ, Donahue LR 1999 Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome 10:10431049.
  • 30
    Benes H, Weinstein RS, Zheng W, Thaden JJ, Jilka RL, Manolagas SC, Reis RJS 2000 Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J Bone Miner Res 15:626633.
  • 31
    Li M, Shen Y, Wronski TJ 1997 Time course of femoral neck osteopenia in ovariectomized rats. Bone 20:5561.
  • 32
    Baldcock PA, Morris HA, Need AG, Moore RJ, Durbridge TC 1998 Variation in the short-term changes in bone cell activity in three regions of the distal femur immediately following ovariectomy. J Bone Miner Res 13:14511457.
  • 33
    Lorenzo JA, Naprta A, Rao Y, Alander C, Glaccum M, Widmer M, Gronowicz G, Kalinowski J, Pilbeam CC 1998 Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139:30223025.
  • 34
    Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T 2000 Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 15:541549.
  • 35
    Lane NE, Kimmel DB, Nilsson MH, Cohen FE, Newton S, Nissenson RA, Strewler GJ 1996 Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model. J Bone Miner Res 11:614625.
  • 36
    Fox J, Miller MA, Stroup GB, Nemeth EF, Miller SC 1997 Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion. Bone 21:163169.
  • 37
    Li M, Liang H, Shen Y, Wronski TJ 1999 Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. Bone 24:95100.
  • 38
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V 1996 Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res 11:421429.
  • 39
    Kagayama M, Sasano Y, Mizoguchi I, Takahashi I 1997 Confocal microscopy of cementocytes and their lacunae and canaliculi in rat molars. Anat Embryol (Berl) 195:491496.
  • 40
    Fermor B, Skerry TM 1995 PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. J Bone Miner Res 10:19351943.
  • 41
    Chow JW, Fox S, Jagger CJ, Chambers TJ 1998 Role for parathyroid hormone in mechanical responsiveness of rat bone. Am J Physiol 274:E146E154.
  • 42
    Hock JM, Gera I 1992 Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:6572.
  • 43
    Shen V, Birchman R, Wu DD, Lindsay R 2000 Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen replacement. J Bone Miner Res 15:740746.
  • 44
    Grier SJ, Turner AS, Alvis MR 1996 The use of dual-energy x-ray absorptiometry in animals. Invest Radiol 31:5062.
  • 45
    Capozza R, Ma YF, Ferretti JL, Meta M, Alippi R, Zanchetta J, Jee WS 1995 Tomographic (pQCT) and biomechanical effects of hPTH(1-38) on chronically immobilized or overloaded rat femurs. Bone 17:233S239S.
  • 46
    Kishi T, Hagino H, Kishimoto H, Nagashima H 1998 Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: Effects of long-term administration, withdrawal, and readministration. Bone 22:515522.
  • 47
    Okimoto N, Tsurukami H, Okazaki Y, Nishida S, Sakai A, Ohnishi H, Hori M, Yasukawa K, Nakamura T 1998 Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats. Bone 22:523531.
  • 48
    Kapadia RD, Stroup GB, Badger AM, Koller B, Levin JM, Coatney RW, Dodds RA, Liang X, Lark MW, Gowen M 1998 Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis. Technol Health Care 6:361372.
  • 49
    Muller R, Van Campenhout H, Van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Ruegsegger P 1998 Morphometric analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed. Bone 23:5966.
  • 50
    Balto K, Muller R, Carrington DC, Dobeck J, Stashenko P 2000 Quantification of periapical bone destruction in mice by micro-computed tomography. J Dent Res 79:3540.
  • 51
    Graichen H, Lochmuller EM, Wolf E, Langkabel B, Stammberger T, Haubner M, Renner-Muller I, Englmeier KH, Eckstein F 1998 A non-destructive technique for 3-D microstructural phenotypic characterisation of bones in genetically altered mice: Preliminary data in growth hormone transgenic animals and normal controls. Anat Embryol 199:239248.
  • 52
    Yamashita T, Nabeshima Y, Noda M 2000 High-resolution micro-computed tomography analyses of the abnormal trabecular bone structures in klotho gene mutant mice. J Endocrinol 164:239245.
  • 53
    Griffin MG, Rupich RC, Avioli LV, Pacifici R 1991 A comparison of dual energy radiography measurements at the lumbar spine and proximal femur for the diagnosis of osteoporosis. J Clin Endocrinol Metab 73:11641169.
  • 54
    Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:26742682.
  • 55
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197207.
  • 56
    Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH 1998 Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone 23:8793.
  • 57
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-Dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315323.
  • 58
    Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM 2000 Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:10851093.